Related references
Note: Only part of the references are listed.Cystatin C Triggers Neuronal Degeneration in a Model of Multiple System Atrophy
Yasuyo Suzuki et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells
Donna Crabtree et al.
JOURNAL OF NEUROCHEMISTRY (2014)
α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation
Jacqueline Burre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells
Ulf Dettmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic Pathogenesis
Konrad Sandhoff et al.
JOURNAL OF NEUROSCIENCE (2013)
Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship
Maria Xilouri et al.
MOLECULAR NEUROBIOLOGY (2013)
Properties of native brain α-synuclein
Jacqueline Burre et al.
NATURE (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Biophysics of α-synuclein membrane interactions
Candace M. Pfefferkorn et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2012)
Cysteine cathepsins: From structure, function and regulation to new frontiers
Vito Turk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer
Bruno Fauvet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Autophagic pathways in Parkinson disease and related disorders
Maria Xilouri et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Conserved C-Terminal Charge Exerts a Profound Influence on the Aggregation Rate of α-Synuclein
Katerina Levitan et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
Biological Function of the Cellular Lipid BMP-BMP as a Key Activator for Cholesterol Sorting and Membrane Digestion
Hichem D. Gallala et al.
NEUROCHEMICAL RESEARCH (2011)
Parkinson's disease involves autophagy and abnormal distribution of cathepsin L
Lingyun Li et al.
NEUROSCIENCE LETTERS (2011)
Lysosomal Degradation of α-Synuclein in Vivo
Sally K. Mak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Integration of Clearance Mechanisms: The Proteasome and Autophagy
Esther Wong et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
The lysosome and neurodegenerative diseases
Lisha Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2009)
The ubiquitin proteasome system in neuropathology
Norman L. Lehman
ACTA NEUROPATHOLOGICA (2009)
Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with α-synuclein genotype
Irit Rappley et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
Valerie Cullen et al.
MOLECULAR BRAIN (2009)
Cathepsin D is the main lysosomal enzyme involved in the degradation of α-synuclein and generation of its carboxy-terminally truncated species
Daniel Sevlever et al.
BIOCHEMISTRY (2008)
Cathepsin D-Many functions of one aspartic protease
Petr Benes et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
alpha-Synuclein Misfolding and Neurodegenerative Diseases
Vladimir N. Uversky
CURRENT PROTEIN & PEPTIDE SCIENCE (2008)
The fold of α-synuclein fibrils
Marcal Vilar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
Liyan Qiao et al.
Molecular Brain (2008)
Role of different regions of α-synuclein in the assembly of fibrils
Zhijie Qin et al.
BIOCHEMISTRY (2007)
The roles of intracellular protein-degradation pathways in neurodegeneration
David C. Rubinsztein
NATURE (2006)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease
Sarah Mueller-Steiner et al.
NEURON (2006)
Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods
Alfred N. Fonteh et al.
DISEASE MARKERS (2006)
Comparison of structure and dynamics of micelle-bound human α-synuclein and Parkinson disease variants
TS Ulmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
WX Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cathepsin B and L are involved in degradation of prions in GTI-1 neuronal cells
KM Luhr et al.
NEUROREPORT (2004)
The association of α-synuclein with membranes affects bilayer structure, stability, and fibril formation
M Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Epitope mapping and specificity of the anti-α-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines
RJ Perrin et al.
NEUROSCIENCE LETTERS (2003)
α-synuclein is degraded by both autophagy and the proteasome
JL Webb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Age-associated changes in central nervous system glycerolipid composition and metabolism
NM Giusto et al.
NEUROCHEMICAL RESEARCH (2002)
Evidence for a partially folded intermediate in α-synuclein fibril formation
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
LC Serpell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
